Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Combining Cognitive-behavioral Therapy with Transcranial Alternating Current for Treating Insomnia

Official title: Evaluation of the Efficacy of Standard Cognitive Behavioural Therapy + Transcranial Alternating Current in the Treatment of Refractory Insomnia Disorder

Run by Xuanwu Hospital, Beijing · NCT06969040 · Data updated 2026-11-12

This study is testing if combining cognitive-behavioral therapy with a brain stimulation technique can help people with stubborn insomnia get better sleep.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedOctober 1, 2025
Study endsNovember 1, 2025
Registry record updatedMay 23, 2025
Trial IDNCT06969040 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who meet the DSM-5 criteria for insomnia and have a Pittsburgh Sleep Quality Index score greater than 5.

Probably not a fit

Patients with severe physical or mental illnesses, sleep breathing disorders, or those currently undergoing psychological therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of combining cognitive-behavioral therapy for insomnia (CBTI) with transcranial alternating current stimulation (tACS) to treat patients with refractory insomnia. The research aims to explore how these two approaches interact to improve sleep quality and duration. By employing a randomized double-blind controlled trial design, the study will assess both the efficacy and safety of this combined treatment method. The goal is to provide clinical data that supports the use of CBTI and tACS together for patients who have not responded to traditional insomnia treatments.

Why it matters

Potential benefit: If successful, this approach could offer a more effective treatment option for patients suffering from refractory insomnia.

How similar studies have gone: While cognitive-behavioral therapy and tACS have shown effectiveness in treating chronic insomnia individually, this combined approach is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Meets the diagnostic criteria for insomnia in DSM-5;
2. Pittsburgh Sleep Quality Index (PSQI) total score\>5 points;
3. Age ≥ 18 years old, with a junior high school education or above;
4. Voluntarily participate in this study and sign an informed consent form.

Exclusion Criteria:

1. Individuals with severe physical or mental illnesses are at risk of suicide;
2. Clinically diagnosed or suspected sleep breathing disorders, restless leg syndrome, and sleep wake rhythm disorders, as well as workers on rotating shifts;
3. Pregnant and lactating women;
4. Currently undergoing any psychological therapy.

Where it's running

  • Xuanwu Hospital, Capital Medical University
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.